This is good news for 2040, and only if we adequately support antibiotic R&D.
This is early research.. Given a lot of time, excellent science, millions of dollars, and some luck, this might be tested in animals and then people. Otherwise, good work like this may never reach patients.

Lord Darzi doing an exceptional job communicating innovation in #AMR

Dr Stephanie Rist, French Minister of Health - describing the economic challenges when antibiotics are thoughtfully protected

Text supporting the One Health model for AMR & humanities and social sciences - #AMR Interesting for the upcoming 5th INAMRSS Research Conference in Munich in coordination with ESMID Global

Excellent One Health model diagram, including AMR and social sciences #AMR

Building the AMR Independent Panel: Lessons and Insights A collaborative initiative to explore models, lessons, and frameworks to support the Independent Panel on Evidence for Action Against Antimicrobial Resistance

The UN will soon unveil a new global science panel on #AMR - what can we do to make it effective and efficient? See the great papers from our conference in Lagos earlier this year: www.cgdev.org/project/buil...

Open Call for Social Science Presentations On Infectious Diseases - Global Strategy Lab INAMRSS was founded to advance social science research on infectious diseases, including but not limited to antimicrobial resistance (AMR). In 2026, we are partnering with ESCMID Global (17-21 April i...

Are you a researcher working in infectious diseases or #AMR, from a social science discipline (broadly interpreted?). INAMRSS has 3 great opportunities for you!

www.globalstrategylab.org/events/open-...

Abstract submission open now - move fast!

The Role of Environmental Governance in Tackling AMR YouTube video by Global Strategy Lab

Issac Weldon from Univ Copenhagen describing what #AMR can learn from environmental governance www.youtube.com/watch?v=f4OS... based on our recent article w Kathleen Liddell (Univ Cambridge) in Milbank: pubmed.ncbi.nlm.nih.gov/40876865/

The AMR Panel Playbook: Eight Lessons for Building an Independent Panel on Antimicrobial Resistance Antimicrobial resistance (AMR) is one of the greatest health challenges of our time, responsible for 1.14 million deaths a year. Failure to keep resistance in check could lead to $1.7 trillion dollars...

The world needs better science to fight drug-resistant infections. #amr

www.cgdev.org/blog/amr-pan...

How should the new Independent Panel on Evidence for Action on #AMR be set up? We gathered scientists and stakeholders - mainly from Africa - to think this through in Lagos, Nigeria. Pre-print now available:

verixiv.org/articles/2-2...

Another gem: "The widespread prevalence of genomic resistance elements observed, therefore, likely reflects intrinsic resistance elements rather than acquired or emergent resistance mechanisms."

Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27 Antimicrobial resistance (AMR) poses an important global health challenge, including insufficient investment in research and development. This study q…

Who should pay for #AMR innovation?

www.sciencedirect.com/science/arti...
@akesselheim.bsky.social

This time with #AMR

New funding opportunity opened today for Gram-negative antibacterial discovery (as late as LO) in therapeutics! gcgh.grandchallenges.org/challenge/in...

Welcome

Why destroy cancer research and cede global scientific leadership to China?

It is not clear how Harvard Law Review peer reviews student notes.

There might be many good reasons to strengthen such inspections, but is zoonotic transmission in USA a top tier risk that should be prioritized now? I’d like to hear from experts on this.

This law student note presumes that important zoonotic jumps from animals to humans occur in the USA, leading to a recommendation to more tightly regulate live animal importation. For most salient examples, such as COVID and HIV/AIDS, zoonotic transmission was outside the USA.

Charting the Path to Tackle AMR: How to Create an Inclusive and Impactful Independent Panel In 2021 alone, AMR killed an estimated 1.14 million people annually—and if countries stick to a business-as-usual approach, it could claim 39 million lives between 2025 and 2050. Beyond the human toll...

Which lessons can be learned from prior international science panels? How can this help the new Independent Panel on Evidence for Action on AMR? www.cgdev.org/blog/chartin...

Great morning session on innovation here at this session led by Prof Sam Kariuki, KEMRI

Now Mingyuan Zhang on the Chinese role in the global antibiotic supply chain, with clever use of antidumping data and trade fairs in her anthropological work.

Next up was Mirza A Portillo, UC Dublin, on some unintended consequences of antibiotic narratives

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

Great morning session on innovation here at this session led by Prof Sam Kariuki, KEMRI

Now Mingyuan Zhang on the Chinese role in the global antibiotic supply chain, with clever use of antidumping data and trade fairs in her anthropological work.

Next up was Mirza A Portillo, UC Dublin, on some unintended consequences of antibiotic narratives

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

Dr Sonia Lewycka on equity discourse in AMR. Most AMR deaths are in lower income settings, so solutions must center equity. (Un)intended Consequences conf @ British Academy.

Nice way to transform Reviewer 2 comments into a paper!